1991Drug and Therapeutics BulletinRequires access

▾ Fosinopril (staril) – another ace inhibitor

Author information unavailable

Open publisher page 0 citations

Abstract

Squibb describe fosinopril as the first of ‘a new class of ACE inhibitor designed and developed for the elderly hypertensive’. It is a pro-drug which is rapidly hydrolysed to the active fosinoprilat. This differs chemically from other ACE inhibitors in that the group which binds to the zinc ion in angiotensin converting enzyme (ACE) is phosphinic acid, instead of sulphydryl as in captopril or carboxylic acid as in enalaprilat and others. The molecule is larger and somewhat more lipophilic than those of earlier ACE inhibitors, and this may explain why a higher proportion is eliminated by the liver.

About this research paper

What this paper is about

Squibb describe fosinopril as the first of ‘a new class of ACE inhibitor designed and developed for the elderly hypertensive’. It is a pro-drug which is rapidly hydrolysed to the active fosinoprilat. This differs chemically from other ACE inhibitors in that the group which binds to the zinc ion in angiotensin converting enzyme (ACE) is phosphinic acid, instead of sulphydryl as in captopril or carboxylic acid as in enalaprilat and others. The molecule is larger and somewhat more lipophilic than those of earlier ACE inhibitors, and this may explain why a higher proportion is eliminated by the liver.

Why it matters

A significance statement is not available in the OpenAlex record.

Key contribution

A contribution statement is not available in the OpenAlex record.

Method / approach

Method details are not available in the OpenAlex metadata.

Main findings

Findings are not separately available in the OpenAlex metadata.

Limitations

Limitations are not available in the OpenAlex metadata.

Applications

Application details are not available in the OpenAlex metadata.

Available abstract

Squibb describe fosinopril as the first of ‘a new class of ACE inhibitor designed and developed for the elderly hypertensive’. It is a pro-drug which is rapidly hydrolysed to the active fosinoprilat. This differs chemically from other ACE inhibitors in that the group which binds to the zinc ion in angiotensin converting enzyme (ACE) is phosphinic acid, instead of sulphydryl as in captopril or carboxylic acid as in enalaprilat and others. The molecule is larger and somewhat more lipophilic than those of earlier ACE inhibitors, and this may explain why a higher proportion is eliminated by the liver.

Key concepts: Enalaprilat, Fosinopril, Captopril, ACE inhibitor, Chemistry, Pharmacology, Angiotensin-converting enzyme, Enzyme inhibitor

Related papers

Back to paper searchBrowse research topicsOriginal source
▾ Fosinopril (staril) – another ace inhibitor — Research Paper | ScholarLens